Sofosbuvir: A comprehensive profile
Funding Sponsor
American University in Cairo
Author's Department
Chemistry Department
Second Author's Department
Chemistry Department
Third Author's Department
Chemistry Department
Find in your Library
https://doi.org/10.1016/bs.podrm.2024.10.003
Document Type
Research Article
Publication Title
Profiles of Drug Substances Excipients and Related Methodology
Publication Date
1-1-2025
doi
10.1016/bs.podrm.2024.10.003
Abstract
Sofosbuvir, a nucleotide analogue, is an antiviral medication that belongs to the class of direct-acting antivirals (DAAs). It is primarily used in the treatment of chronic hepatitis C virus (HCV) infections. Sofosbuvir works by inhibiting the replication of HCV, disrupting its ability to produce RNA and effectively reducing the viral load in the body. This chapter offers a comprehensive examination of sofosbuvir, including its nomenclature, physiochemical attributes, synthesis, and thermal analysis. Furthermore, it presents various analytical methods employed for both spectrophotometric and chromatographic assessments of sofosbuvir in different matrices.
First Page
1
Last Page
41
Recommended Citation
APA Citation
Lababidi, J.
Kabil, M.
&
Azzazy, H.
(2025). Sofosbuvir: A comprehensive profile. Profiles of Drug Substances Excipients and Related Methodology, 50, 1–41.
https://doi.org/10.1016/bs.podrm.2024.10.003
MLA Citation
Lababidi, Jude Majed, et al.
"Sofosbuvir: A comprehensive profile." Profiles of Drug Substances Excipients and Related Methodology, vol. 50, 2025, pp. 1–41.
https://doi.org/10.1016/bs.podrm.2024.10.003
